Browsing by Author "Sacramento, Carolina Q."
Now showing items 31-42 of 42
-
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV‑2 and Potential Mechanisms
Puhl, A. C. et al. | Date Issued: 2021 -
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
Ferreira, André C. et al. | Date Issued: 2021 -
SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites
Lechuga, Guilherme Curty et al. | Date Issued: 2021 -
Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages
Ferreira, André C. et al. | Date Issued: 2023 -
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
Teixeira, Lívia et al. | Date Issued: 2022 -
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Sacramento, Carolina Q. et al. | Date Issued: 2017 -
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2
Melgaço, Juliana Gil et al. | Date Issued: 2021 -
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
Sacramento, Carolina Q. et al. | Date Issued: 2022 -
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants
Sacramento, Carolina Q. et al. | Date Issued: 2021 -
VIP plasma levels associate with survival in severe COVID-19 patients, correlatingwith protective effects in SARS-CoV-2-infected cells
Temerozo, Jairo R. et al. | Date Issued: 2022 -
WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
Aragão, Luiz Guilherme H. S. et al. | Date Issued: 2021 -
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
Freitas, Caroline S. de et al. | Date Issued: 2019